Related Experiment Video

Updated: Dec 1, 2025

A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects
05:46

A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects

Published on: May 4, 2021

5.5K

Evidence-based treatment during the SARS-CoV-2 pandemic: Identifying the knowns and unknowns of nebulization

J Andrew Woods

    Journal of the American Pharmacists Association : Japha
    |November 8, 2020
    PubMed

    Insights

    This commentary discusses the lack of evidence regarding nebulization and coronavirus transmission. It addresses concerns about delivering inhaled bronchodilators to COVID-19 patients due to potential SARS-CoV-2 aerosolization risks.

    Area of Science:

    • Pulmonary Medicine
    • Infectious Diseases
    • Respiratory Care

    Background:

    • The COVID-19 pandemic, caused by SARS-CoV-2, presents significant public health challenges.
    • Optimal delivery of inhaled bronchodilators is crucial for managing respiratory conditions, including COVID-19.
    • Concerns exist regarding potential SARS-CoV-2 transmission via aerosolized droplets during nebulizer treatments for COVID-19 patients.

    Purpose of the Study:

    • To discuss the current lack of scientific evidence on nebulization and coronavirus transmission.
    • To address heightened concerns about the risks associated with nebulized treatments in COVID-19 patients.

    Main Methods:

    • Commentary based on existing literature and expert opinion.
    • Discussion of the theoretical risks of aerosol generation during nebulization.
    • Review of the transmission routes of coronaviruses.

    Main Results:

    • There is a notable absence of direct evidence linking nebulizer treatments to SARS-CoV-2 transmission.
    • The commentary highlights the need for evidence-based guidelines rather than solely relying on theoretical risks.

    Conclusions:

    • Further research is needed to definitively assess the risk of SARS-CoV-2 transmission during nebulization.
    • Clinical decisions regarding bronchodilator delivery in COVID-19 patients should be guided by available evidence and risk-benefit assessments.

    More Related Videos

    Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic09:03

    Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic

    Published on: November 7, 2020

    5.2K
    Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device09:36

    Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

    Published on: September 24, 2020

    3.0K

    Related Concept Videos

    Pneumonia IV: Management01:28

    Pneumonia IV: Management

    The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
    Bacterial Pneumonia Treatment
    For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
    623
    Pulmonary Tuberculosis V01:28

    Pulmonary Tuberculosis V

    Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
    Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
    346
    Acute Respiratory Failure-V01:29

    Acute Respiratory Failure-V

    The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
    Ensure that patients are monitored continuously for their response to therapy, including changes in...
    322
    Pneumonia V: Nursing management and Prevention01:30

    Pneumonia V: Nursing management and Prevention

    Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
    The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
    Enhance airway patency
    Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
    3.1K
    Drugs Used in Lower Respiratory Disorders: Overview01:17

    Drugs Used in Lower Respiratory Disorders: Overview

    Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
    Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
    864
    Chronic Obstructive Pulmonary Disease-V: Management01:29

    Chronic Obstructive Pulmonary Disease-V: Management

    Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
    Smoking Cessation
    2.9K